The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
POC Infectious Diseases-Global Market Insights and Sales Trends 2024
Synopsis
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
The global POC Infectious Diseases market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of POC Infectious Diseases in various end use industries. The expanding demands from the Hospital& Clinics, Clinical Diagnostic Laboratories and Homecare Settings,, are propelling POC Infectious Diseases market. Flu, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adenovirus segment is estimated at % CAGR for the next seven-year period.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for POC Infectious Diseases, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global POC Infectious Diseases market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global POC Infectious Diseases market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, POC Infectious Diseases sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of POC Infectious Diseases covered in this report include Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad and Cepheid, etc.
The global POC Infectious Diseases market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem
Global POC Infectious Diseases market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global POC Infectious Diseases market, Segment by Type:
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Global POC Infectious Diseases market, by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of POC Infectious Diseases companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
The global POC Infectious Diseases market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of POC Infectious Diseases in various end use industries. The expanding demands from the Hospital& Clinics, Clinical Diagnostic Laboratories and Homecare Settings,, are propelling POC Infectious Diseases market. Flu, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adenovirus segment is estimated at % CAGR for the next seven-year period.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for POC Infectious Diseases, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global POC Infectious Diseases market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global POC Infectious Diseases market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, POC Infectious Diseases sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of POC Infectious Diseases covered in this report include Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad and Cepheid, etc.
The global POC Infectious Diseases market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem
Global POC Infectious Diseases market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global POC Infectious Diseases market, Segment by Type:
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Global POC Infectious Diseases market, by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of POC Infectious Diseases companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of POC Infectious Diseases
1.1 POC Infectious Diseases Market Overview
1.1.1 POC Infectious Diseases Product Scope
1.1.2 POC Infectious Diseases Market Status and Outlook
1.2 Global POC Infectious Diseases Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global POC Infectious Diseases Market Size by Region (2018-2029)
1.4 Global POC Infectious Diseases Historic Market Size by Region (2018-2023)
1.5 Global POC Infectious Diseases Market Size Forecast by Region (2024-2029)
1.6 Key Regions, POC Infectious Diseases Market Size (2018-2029)
1.6.1 North America POC Infectious Diseases Market Size (2018-2029)
1.6.2 Europe POC Infectious Diseases Market Size (2018-2029)
1.6.3 Asia-Pacific POC Infectious Diseases Market Size (2018-2029)
1.6.4 Latin America POC Infectious Diseases Market Size (2018-2029)
1.6.5 Middle East & Africa POC Infectious Diseases Market Size (2018-2029)
2 POC Infectious Diseases Market by Type
2.1 Introduction
2.1.1 Flu
2.1.2 Adenovirus
2.1.3 Malaria
2.1.4 Streptococcal Bacteremia
2.1.5 Tuberculosis (TB)
2.1.6 Occult Blood
2.1.7 HIV
2.2 Global POC Infectious Diseases Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global POC Infectious Diseases Historic Market Size by Type (2018-2023)
2.2.2 Global POC Infectious Diseases Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.2 Europe POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
3 POC Infectious Diseases Market Overview by Application
3.1 Introduction
3.1.1 Hospital& Clinics
3.1.2 Clinical Diagnostic Laboratories
3.1.3 Homecare Settings
3.2 Global POC Infectious Diseases Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global POC Infectious Diseases Historic Market Size by Application (2018-2023)
3.2.2 Global POC Infectious Diseases Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.2 Europe POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
4 POC Infectious Diseases Competition Analysis by Players
4.1 Global POC Infectious Diseases Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2022)
4.3 Date of Key Players Enter into POC Infectious Diseases Market
4.4 Global Top Players POC Infectious Diseases Headquarters and Area Served
4.5 Key Players POC Infectious Diseases Product Solution and Service
4.6 Competitive Status
4.6.1 POC Infectious Diseases Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott POC Infectious Diseases Products, Services and Solutions
5.1.4 Abbott POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Meridian Bioscience
5.2.1 Meridian Bioscience Profile
5.2.2 Meridian Bioscience Main Business
5.2.3 Meridian Bioscience POC Infectious Diseases Products, Services and Solutions
5.2.4 Meridian Bioscience POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.2.5 Meridian Bioscience Recent Developments
5.3 Orasure Technologies
5.3.1 Orasure Technologies Profile
5.3.2 Orasure Technologies Main Business
5.3.3 Orasure Technologies POC Infectious Diseases Products, Services and Solutions
5.3.4 Orasure Technologies POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.3.5 Trinity Biotech Recent Developments
5.4 Trinity Biotech
5.4.1 Trinity Biotech Profile
5.4.2 Trinity Biotech Main Business
5.4.3 Trinity Biotech POC Infectious Diseases Products, Services and Solutions
5.4.4 Trinity Biotech POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.4.5 Trinity Biotech Recent Developments
5.5 Beckman Coulter/ Danaher
5.5.1 Beckman Coulter/ Danaher Profile
5.5.2 Beckman Coulter/ Danaher Main Business
5.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Products, Services and Solutions
5.5.4 Beckman Coulter/ Danaher POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter/ Danaher Recent Developments
5.6 Becton Dickinson
5.6.1 Becton Dickinson Profile
5.6.2 Becton Dickinson Main Business
5.6.3 Becton Dickinson POC Infectious Diseases Products, Services and Solutions
5.6.4 Becton Dickinson POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.6.5 Becton Dickinson Recent Developments
5.7 Biomerieux
5.7.1 Biomerieux Profile
5.7.2 Biomerieux Main Business
5.7.3 Biomerieux POC Infectious Diseases Products, Services and Solutions
5.7.4 Biomerieux POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.7.5 Biomerieux Recent Developments
5.8 Bio-Rad
5.8.1 Bio-Rad Profile
5.8.2 Bio-Rad Main Business
5.8.3 Bio-Rad POC Infectious Diseases Products, Services and Solutions
5.8.4 Bio-Rad POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Recent Developments
5.9 Cepheid
5.9.1 Cepheid Profile
5.9.2 Cepheid Main Business
5.9.3 Cepheid POC Infectious Diseases Products, Services and Solutions
5.9.4 Cepheid POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.9.5 Cepheid Recent Developments
5.10 Diamedix
5.10.1 Diamedix Profile
5.10.2 Diamedix Main Business
5.10.3 Diamedix POC Infectious Diseases Products, Services and Solutions
5.10.4 Diamedix POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.10.5 Diamedix Recent Developments
5.11 Diasorin
5.11.1 Diasorin Profile
5.11.2 Diasorin Main Business
5.11.3 Diasorin POC Infectious Diseases Products, Services and Solutions
5.11.4 Diasorin POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.11.5 Diasorin Recent Developments
5.12 Eiken Chemical
5.12.1 Eiken Chemical Profile
5.12.2 Eiken Chemical Main Business
5.12.3 Eiken Chemical POC Infectious Diseases Products, Services and Solutions
5.12.4 Eiken Chemical POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.12.5 Eiken Chemical Recent Developments
5.13 Enzo Biochem
5.13.1 Enzo Biochem Profile
5.13.2 Enzo Biochem Main Business
5.13.3 Enzo Biochem POC Infectious Diseases Products, Services and Solutions
5.13.4 Enzo Biochem POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.13.5 Enzo Biochem Recent Developments
6 North America
6.1 North America POC Infectious Diseases Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 POC Infectious Diseases Market Dynamics
11.1 POC Infectious Diseases Industry Trends
11.2 POC Infectious Diseases Market Drivers
11.3 POC Infectious Diseases Market Challenges
11.4 POC Infectious Diseases Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
